Subject:
Hot Off The Wire: XILLIX TECHNOLOGIES CORP.
Date:
Mon, 24 Aug 1998 13:32:28 -0400
From:
cthompson@cdn-news.com
To:
cthompson@cdn-news.com
===================================================================
Canadian Corporate News --- Hot Off The Wire
News Release for XILLIX TECHNOLOGIES CORP.
===================================================================
-------------------------------------------------------------------
E*TRADE Canada introduces another exclusive!
Pay NO COMMISSIONS on over 600 mutual funds
For more information visit us at:
www2.cdn-news.com
-------------------------------------------------------------------
NEWS RELEASE TRANSMITTED BY CANADIAN CORPORATE NEWS
FOR: XILLIX TECHNOLOGIES CORP.
TSE SYMBOL: XLX
AUGUST 24, 1998
Xillix Technologies Issues Statement
RICHMOND, BRITISH COLUMBIA--At the request of the Toronto Stock
Exchange, Xillix Technologies Corp. released the following
statement:
"The Company does not have any pending announcements, not is it
aware of any developments or issues with respect to its
operations, products of ownership structure, which would explain
the current downward movement in the price of its common shares."
Sales of the Xillix LIFE-Lung Fluorescence Endoscopy System (TM),
by Olympus Optical Co. Ltd., continue to meet the Company's sales
projections; clinical testing of the Xillix LIFE-GI Fluorescence
Endoscopy System (TM), for the early detection of gastrointestinal
cancer, are currently underway; and the Company is exploring new
applications for its patented fluorescence endoscopy system in the
area of cervical, bladder, head and neck cancers.
Xillix Technologies Corp. is a leader in the development and
commercialization of proprietary medical imaging technology which
helps physicians diagnose early-stage cancer. When tissue
containing abnormal cells is exposed to light from Xillix's
fluorescence imaging devices, physicians are able to detect
precancerous and cancerous cells.
The Company's lead product, called the Xillix LIFE-Lung
Fluorescence Endoscopy System has been approved for sale in the
United States, Canada, Europe and Japan. Worldwide marketing has
been granted to Olympus Optical Co. Ltd., of Tokyo, the
international endoscopy market leader. Xillix has also formed a
strategic alliance with Miravant Medical Technologies of Santa
Barbara, California, to co-develop medical devices for early
cancer detection, localization and treatment.
-30-
FOR FURTHER INFORMATION PLEASE CONTACT:
Xillix Technologies Corp.
Laurie McMichael
Manager, Investor Relations and Corporate Communications
(604) 278-5000
(604) 278-3356 (FAX)
website: www.xillix.com |
